{
    "id": 18536,
    "fullName": "TP53 H168R",
    "impact": "missense",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "TP53 H168R lies within the DNA-binding domain of the Tp53 protein (PMID: 22713868). H168R confers a loss of function to the Tp53 protein, as demonstrated by decreased Tp53 transactivation activity and decreased induction of apoptosis in cell culture (PMID: 18996393).",
            "references": [
                {
                    "id": 4678,
                    "pubMedId": 18996393,
                    "title": "Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/18996393"
                },
                {
                    "id": 2397,
                    "pubMedId": 22713868,
                    "title": "Mutant p53: one name, many proteins.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22713868"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 7157,
        "geneSymbol": "TP53",
        "terms": [
            "TP53",
            "BCC7",
            "BMFS5",
            "LFS1",
            "P53",
            "TRP53"
        ]
    },
    "variant": "H168R",
    "createDate": "02/24/2016",
    "updateDate": "10/02/2018",
    "referenceTranscriptCoordinates": {
        "id": 94442,
        "transcript": "NM_000546",
        "gDna": "chr17:g.7675109T>C",
        "cDna": "c.503A>G",
        "protein": "p.H168R",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 4734,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Xalkori (crizotinib) did not improve the effect of Topotecan and Cytoxan (cyclophosphamide) on tumor growth suppression in xenograft models of a human neuroblastoma cell line harboring wild-type ALK and TP53 H168R (PMID: 26438783).",
            "molecularProfile": {
                "id": 18884,
                "profileName": "ALK wild-type TP53 H168R"
            },
            "therapy": {
                "id": 3601,
                "therapyName": "Crizotinib + Cyclophosphamide + Topotecan",
                "synonyms": null
            },
            "indication": {
                "id": 769,
                "name": "neuroblastoma",
                "source": "DOID"
            },
            "responseType": "no benefit",
            "references": [
                {
                    "id": 4681,
                    "pubMedId": 26438783,
                    "title": "Crizotinib Synergizes with Chemotherapy in Preclinical Models of Neuroblastoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26438783"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 18881,
            "profileName": "TP53 H168R",
            "profileTreatmentApproaches": [
                {
                    "id": 7882,
                    "name": "p53 Activator",
                    "profileName": "TP53 H168R"
                },
                {
                    "id": 7883,
                    "name": "p53 Gene Therapy",
                    "profileName": "TP53 H168R"
                }
            ]
        },
        {
            "id": 18884,
            "profileName": "ALK wild-type TP53 H168R",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 94442,
            "transcript": "NM_000546",
            "gDna": "chr17:g.7675109T>C",
            "cDna": "c.503A>G",
            "protein": "p.H168R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 94444,
            "transcript": "NM_001126114",
            "gDna": "chr17:g.7675109T>C",
            "cDna": "c.503A>G",
            "protein": "p.H168R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 94441,
            "transcript": "NM_001126112",
            "gDna": "chr17:g.7675109T>C",
            "cDna": "c.503A>G",
            "protein": "p.H168R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 94443,
            "transcript": "NM_001126113",
            "gDna": "chr17:g.7675109T>C",
            "cDna": "c.503A>G",
            "protein": "p.H168R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}